Price
Financials
Consolidated, Rs crore| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 9.41 | 11.79 | 9.78 | 15.26 | 12.93 | 23.25 | 30.58 | 34.29 |
| Expenses | 4.55 | 7.19 | 7.17 | 6.64 | 7.81 | 16.35 | 24.28 | 25.92 |
| Operating Profit | 4.86 | 4.60 | 2.61 | 8.62 | 5.12 | 6.90 | 6.30 | 8.37 |
| OPM % | 51.65% | 39.02% | 26.69% | 56.49% | 39.60% | 29.68% | 20.60% | 24.41% |
| Other Income | 0.04 | 0.05 | 0.05 | 0.01 | 0.09 | 0.06 | 0.71 | 0.69 |
| Interest | 0.16 | 0.17 | 0.16 | 0.18 | 0.28 | 0.60 | 0.82 | 0.66 |
| Depreciation | 0.74 | 0.88 | 0.90 | 0.96 | 0.90 | 1.33 | 1.51 | 1.44 |
| Profit before tax | 4.00 | 3.60 | 1.60 | 7.49 | 4.03 | 5.03 | 4.68 | 6.96 |
| Tax % | 26.25% | 29.72% | 16.88% | 27.77% | 28.54% | 26.44% | -2.99% | 23.56% |
| Net Profit | 2.96 | 2.53 | 1.34 | 5.40 | 2.88 | 3.70 | 4.82 | 5.32 |
| EPS in Rs | 18.39 | 15.53 | 0.23 | 0.85 | 0.47 | 0.37 | 0.64 | 0.66 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|
| Sales | 0 | 5 | 40 | 82 | 101 |
| Expenses | 0 | 3 | 24 | 55 | 74 |
| Operating Profit | -0 | 2 | 17 | 27 | 27 |
| OPM % | 41% | 41% | 33% | 26% | |
| Other Income | 0 | 1 | 0 | 1 | 2 |
| Interest | 0 | 0 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 3 | 5 | 5 |
| Profit before tax | -0 | 2 | 13 | 21 | 21 |
| Tax % | 0% | 25% | 26% | 21% | |
| Net Profit | -0 | 2 | 10 | 17 | 17 |
| EPS in Rs | -0.50 | 85.50 | 1.66 | 1.97 | 2.14 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | 119% | ||
| Compounded Profit Growth | % | % | 1058% | 37% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | % | 16% | 11% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0.20 | 0.20 | 11 | 16 |
| Reserves | 0 | 11 | 15 | 237 |
| Borrowings | 0 | 6 | 8 | 29 |
| Other Liabilities | 4 | 4 | 21 | 16 |
| Total Liabilities | 4 | 21 | 55 | 298 |
| Fixed Assets | 0 | 14 | 31 | 129 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 12 |
| Other Assets | 4 | 7 | 24 | 157 |
| Total Assets | 4 | 21 | 55 | 298 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from Operating Activity | 0 | 1 | 14 | -4 |
| Cash from Investing Activity | 0 | 0 | -18 | -214 |
| Cash from Financing Activity | 0 | -0 | 6 | 228 |
| Net Cash Flow | 0 | 1 | 2 | 11 |
| Free Cash Flow | 0 | 2 | -5 | -98 |
| CFO/OP | 0% | 70% | 99% | 21% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 321 | 138 | 172 | |
| Inventory Days | ||||
| Days Payable | ||||
| Cash Conversion Cycle | 321 | 138 | 172 | |
| Working Capital Days | 100 | -24 | 91 | |
| ROCE % | 19% | 52% | 14% |
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Promoters | 71.45% | 71.45% | 71.45% |
| FIIs | 10.47% | 4.89% | 4.89% |
| DIIs | 1.67% | 0.56% | 0.56% |
| Public | 16.40% | 23.10% | 23.10% |
| No. of Shareholders | 27,783 | 18,301 | 18,301 |
Fundamentals
Market Cap₹ 1,394 Cr.
Current Price₹ 176
Stock P/E88.0
Book Value₹ 32.0
ROCE14.5 %
ROE11.1 %
Dividend Yield0.00 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)119%
Compounded Profit Growth (TTM)37%
Consolidated figures.
Ownership
Promoter holding71.45%
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | GKSL | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +13.7% | -2.8% | +16.5 pts |
| 1 month | +19.6% | -6.8% | +26.4 pts |
| 3 months | +49.6% | -7.6% | +57.3 pts |
| 6 months | +91.7% | +0.4% | +91.3 pts |
1 mutual fund schemes hold about ₹0 Cr.
Over three months 0 bought more and 1 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Bandhan BSE Healthcare Index Fund | 0.02% | 0 | -22% |
Red flags
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹34 Cr +124.7% vs Jun 2025.
Net profit ₹5 Cr -1.5%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
| Date | Client | Side | Qty | Price |
|---|---|---|---|---|
| 2026-10-01 | Vinsul Makardi Ltd | SELL | 815,778 | 198.74 |
| 2026-10-01 | Vinsul Makardi Ltd | BUY | 815,778 | 198.41 |
| 2026-10-01 | Stackin Private Limited | SELL | 555,811 | 197.94 |
| 2026-10-01 | Stackin Private Limited | BUY | 555,811 | 197.66 |
| 2026-10-01 | Qe Securities Llp | SELL | 933,215 | 197.68 |
| 2026-10-01 | Qe Securities Llp | BUY | 942,710 | 197.12 |
| 2026-10-01 | Priyal Bohra | SELL | 399,546 | 193.41 |
| 2026-10-01 | Priyal Bohra | BUY | 399,546 | 195.84 |
| 2026-10-01 | Nk Securities Research Private Limited | SELL | 1,030,937 | 199.93 |
| 2026-10-01 | Nk Securities Research Private Limited | BUY | 1,030,937 | 199.83 |
| 2026-10-01 | Natvarsinh T Chavda | SELL | 423,483 | 199.75 |
| 2026-10-01 | Natvarsinh T Chavda | BUY | 302,285 | 194.40 |
| 2026-10-01 | Microcurves Trading Private Limited | SELL | 1,498,972 | 200.04 |
| 2026-10-01 | Microcurves Trading Private Limited | BUY | 1,498,972 | 199.79 |
| 2026-10-01 | Junomoneta Finsol Private Limited | SELL | 1,502,241 | 199.10 |
| 2026-10-01 | Junomoneta Finsol Private Limited | BUY | 1,503,223 | 198.86 |
| 2026-10-01 | J4S Financial Solutions Llp | SELL | 857,633 | 198.30 |
| 2026-10-01 | J4S Financial Solutions Llp | BUY | 857,633 | 198.02 |
| 2026-10-01 | Irage Broking Services Llp | SELL | 420,664 | 199.56 |
| 2026-10-01 | Irage Broking Services Llp | BUY | 465,899 | 199.98 |
| 2026-10-01 | Imc India Securities Private Limited | SELL | 444,824 | 200.99 |
| 2026-10-01 | Imc India Securities Private Limited | BUY | 441,611 | 199.32 |
| 2026-10-01 | Hrti Private Limited | SELL | 563,833 | 197.49 |
| 2026-10-01 | Hrti Private Limited | BUY | 550,058 | 196.72 |
| 2026-10-01 | Grt Strategic Ventures Llp | SELL | 570,047 | 198.93 |
| 2026-10-01 | Grt Strategic Ventures Llp | BUY | 570,047 | 198.85 |
| 2026-10-01 | Alphagrep Securities Private Limited | SELL | 613,390 | 198.53 |
| 2026-10-01 | Alphagrep Securities Private Limited | BUY | 613,390 | 198.29 |
No corporate actions on record.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Close to Close price movement greater than 75perc in previous 6 monthsHigh low price variation greater than 100perc in previous 6 monthsScrip PE is greater than 50 (4 trailing quarters)